Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the ...
由于在Ventolin尝到了甜头,GSK分别在1990年与1993年于英国上市了‌沙美特罗(Serevent)与氟替卡松(Flovent)。 沙美特罗是一种长效β2肾上腺素受体 ...
The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...